Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-21-140447
Filing Date
2021-04-29
Accepted
2021-04-29 16:14:56
Documents
3
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d105868d10ka.htm 10-K/A 290849
2 EX-31.1 d105868dex311.htm EX-31.1 3606
3 EX-31.2 d105868dex312.htm EX-31.2 3560
  Complete submission text file 0001193125-21-140447.txt   299045
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39634 | Film No.: 21870761
SIC: 2834 Pharmaceutical Preparations